Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections
Abstract Effective strategies to manage Burkholderia cepacia complex (Bcc) infections in cystic fibrosis (CF) patients are lacking. We tested combinations of clinically available antibiotics and show that moxifloxacin-ceftazidime could inhibit 16 Bcc clinical isolates at physiologically achievable c...
Main Authors: | Omar M. El-Halfawy, Marwa M. Naguib, Miguel A. Valvano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-017-0279-8 |
Similar Items
-
Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance
by: Douglas Gordon Storey, et al.
Published: (2015-07-01) -
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
by: Bryan A. Garcia, et al.
Published: (2018-02-01) -
Burkholderia cepacia Complex Vaccines: Where Do We Go from here?
by: Gonzalo A. Pradenas, et al.
Published: (2016-04-01) -
Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
by: Alex eHorsley, et al.
Published: (2011-12-01) -
Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada
by: David P. Speert, et al.
Published: (2002-02-01)